# A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

> **NCT04456296** · PHASE4 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 673 (actual)

## Conditions studied

- Hypogonadism
- Hypogonadism, Male
- Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** Aveed Injectable Product
- **DRUG:** Fortesta
- **DRUG:** Testim

## Key facts

- **NCT ID:** NCT04456296
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-30
- **Primary completion:** 2023-07-12
- **Final completion:** 2023-07-12
- **Target enrollment:** 673 (ACTUAL)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04456296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04456296, "A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04456296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*